GAMIDA CELL LTD's ticker is GMDA and the CUSIP is M47364100. A total of 66 filers reported holding GAMIDA CELL LTD in Q2 2023. The put-call ratio across all filers is 0.09 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $82,965 | – | 42,987 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Stonepine Capital Management, LLC | 1,724,201 | $6,759,000 | 3.08% |
| Healthcare Value Capital, LLC | 100,000 | $392,000 | 0.77% |
| Yahav Achim Ve Achayot - Provident Funds Management Co Ltd. | 175,000 | $686,000 | 0.54% |
| Laird Norton Wetherby Trust Company, LLC | 529,103 | $2,074,000 | 0.21% |
| Rock Springs Capital Management LP | 2,147,400 | $8,418,000 | 0.18% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 107,000 | $418,000 | 0.10% |
| Platform Technology Partners | 55,875 | $219,000 | 0.10% |
| FIRST MIDWEST BANK TRUST DIVISION | 139,331 | $546,000 | 0.08% |
| Guild Investment Management, Inc. | 18,000 | $71,000 | 0.07% |
| Virtus ETF Advisers LLC | 33,121 | $130,000 | 0.06% |